[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351479-105":59,"doc-detail-351479-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","prognostic-significance-of-msi-and-ebv-positivity-in-pd-l1-positive-gastric-cancer-a-systematic-review-and-meta-analysis","Prognostic Significance of MSI and EBV Positivity in PD-L1 Positive Gastric Cancer - A Systematic Review and Meta-Analysis","","Microsatellite instability (MSI), programmed death-ligand 1 (PD-L1) expression, and Epstein–Barr virus (EBV) positivity are emerging biomarkers for gastric cancer prognosis and immunotherapy selection. This systematic review and meta-analysis evaluated their prognostic significance using studies from PubMed, EMBASE, and the Cochrane Library (January 2010 to December 2024). Twenty-five studies (6494 patients) were included, with data pooled using random-effects models and heterogeneity assessed via I2 and Cochran’s Q.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prognostic-significance-of-msi-and-ebv-positivity-in-pd-l1-positive-gastric-cancer-a-systematic-review-and-meta-analysis/351479/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prognostic-significance-of-msi-and-ebv-positivity-in-pd-l1-positive-gastric-cancer-a-systematic-review-and-meta-analysis/351479.png","ImageObject",300,407,{"name":92,"@type":93},"Angel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Which biomarkers were assessed for prognosis in this review?","Question",{"text":112,"@type":113},"The review assessed microsatellite instability (MSI), PD-L1 expression, and Epstein–Barr virus (EBV) positivity in gastric cancer and evaluated their prognostic significance.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What time range and databases were used to identify included studies?",{"text":117,"@type":113},"Relevant studies were analyzed from PubMed, EMBASE, and the Cochrane Library, covering January 2010 to December 2024.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the main findings regarding MSI and outcomes in localized gastric cancer?",{"text":121,"@type":113},"In localized disease, MSI-high status was associated with improved disease-free survival (DFS) but did not show a significant impact on overall survival (OS) compared with microsatellite stable/PD-L1-negative tumors.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351479,1790212274,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},687207412472,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Cancer Medicine  \nREVIEW  OPEN ACCESS   \nPrognostic Significance of MSI and EBV Positivity in PD-L1 Positive Gastric Cancer: A Systematic Review and Meta-Analysis  \nFausto Petrelli1  | Maria Antista2  | Antonio Ghidini3 | Valentina Rampulla4 | Lorenzo Dottorini1 | Andrea Celotti5  | Fulvia Milena Cribiu6 | Barbara Galassi7 | Ornella Garrone7 | Alberto Zaniboni8 | Gianluca Tomasello2 | Michele Ghidini7  \n1Oncology Unit, ASST Bergamo Ovest, Treviglio, Italy | 2Oncology Unit, ASST Crema, Crema, Italy | 3Oncology Unit, Casa di Cura Igea, Milano, Italy | 4Surgery Unit, ASST Bergamo Ovest, Treviglio, Italy | 5Surgery Unit, ASST Cremona, Cremona, Italy | 6Pathology Unit, ASST Bergamo Ovest, Treviglio, Italy | 7Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy | 8Oncology Unit, Fondazione Poliambulanza, Brescia, Italy  \nCorrespondence: Fausto Petrelli ([faupe@libero.it](faupe@libero.it))  \nReceived: 8 March 2025 | Revised: 19 January 2026 | Accepted: 26 February 2026  \nKeywords: EBV | gastric cancer | meta-analysis | MSI | PD-L1 | prognosis  \nABSTRACT  \nBackground and Aims: Microsatellite instability (MSI), programmed death-ligand 1 (PD-L1) expression, and Epstein–Barr virus (EBV) positivity are emerging biomarkers in gastric cancer prognosis and treatment selection, particularly in immunotherapy. This review evaluates their prognostic significance through a systematic review and meta-analysis.  \nMethods: Relevant studies from PubMed, EMBASE, and the Cochrane Library (January 2010 to December 2024) were analyzed. Studies included assessing MSI, PD-L1, and EBV status in gastric cancer using immunohistochemistry, PCR, or in situ hybridization, and reported outcomes such as overall survival (OS), disease-free survival (DFS), or progression-free survival. Data extraction adhered to PRISMA guidelines, and pooled analyses were conducted using a random-effects model (DerSimonian-Laird method). Heterogeneity was assessed using I2 statistics and Cochran's Q test.  \nResults: A total of 25 studies involving 6494 patients were reviewed. In localized gastric cancer, MSI-high status was associated with significantly improved DFS (hazard ratio [HR], 0.42; 95% confidence interval [CI], 0.23–0.75; p = 0.004) but showed no significant impact on OS (HR, 0.78; 95% CI, 0.48–1.28; p = 0.33) compared to microsatellite stable/PD-L1-negative tumors. EBVpositive/PD-L1-positive cancers demonstrated a prognosis similar to EBV-negative/PD-L1-negative cases (OS: HR, 1.08; 95% CI, 0.81–1.45; p = 0.59) .  \nConclusions: In metastatic disease, MSI and EBV status were not associated with significant prognostic effects. MSI and EBV status have minimal prognostic value in gastric cancer, particularly for OS, but are essential for selecting candidates for immune checkpoint inhibitors. Standardizing biomarker evaluation is critical to enhancing their clinical relevance.  \n1 | Introduction  \nGastric cancer remains a major global health burden, ranking as the fifth most common malignancy and the fourth leading cause of cancer-related mortality worldwide, with an estimated 1.09 million new cases and 769,000 deaths annually [1] . Despite  \nadvances in multimodal treatment approaches, the prognosis for gastric cancer patients remains poor, with 5-year survival rates ranging from 20% to 40% in most regions [2] . The heterogeneous biology of gastric cancer contributes to variable treatment outcomes, emphasizing the need for precision medicine approaches and reliable prognostic biomarkers [3] .  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2026 The Author(s). Cancer Medicine published by John Wiley & Sons Ltd.  \nCancer Medicine, 2026; 15:e71711 1 of 10  \n[https://doi.org/10.1002/cam4.71711](https://doi.org/10.1002/cam4.71711)  \nMicrosatellite instability (MSI) and programmed death-lig","cbCaio5jkRuyrYX0","https://ap.wps.com/l/cbCaio5jkRuyrYX0","pdf",1194374,"English","# Abstract\n## Background and Aims\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"Which biomarkers were assessed for prognosis in this review?\",\"answer\":\"The review assessed microsatellite instability (MSI), PD-L1 expression, and Epstein–Barr virus (EBV) positivity in gastric cancer and evaluated their prognostic significance.\"},{\"question\":\"What time range and databases were used to identify included studies?\",\"answer\":\"Relevant studies were analyzed from PubMed, EMBASE, and the Cochrane Library, covering January 2010 to December 2024.\"},{\"question\":\"What were the main findings regarding MSI and outcomes in localized gastric cancer?\",\"answer\":\"In localized disease, MSI-high status was associated with improved disease-free survival (DFS) but did not show a significant impact on overall survival (OS) compared with microsatellite stable/PD-L1-negative tumors.\"}]","Prognostic Significance of MSI and EBV Positivity in PD-L1 Positive Gastric Cancer - A Systematic Review and Meta-Analysis | PDF",1790094349,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/66aa9be7eb340c51004c13527b7c3d67.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/53c252e1978a82b6b5288ebb8e937924.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5d2fa9870afeb8aa1ab2071f97e67621.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9dc11cfdcea1028faeb4e72cff901e73.webp",980,1287]